Copyright
©The Author(s) 2025.
World J Diabetes. Feb 15, 2025; 16(2): 97287
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.97287
Published online Feb 15, 2025. doi: 10.4239/wjd.v16.i2.97287
Figure 4 Effects of dapagliflozin pretreatment on the human monocyte cell line cell viability.
Cell viability was measured with a cell counting kit 8. The data are presented as percentages, and the experiment was independently repeated 3 times. 1P < 0.05 vs control group (100 μM, 24 hours).
- Citation: Xiong SX, Huang LJ, Liu HS, Zhang XX, Li M, Cui YB, Shao C, Hu XL. Dapagliflozin exerts anti-apoptotic effects by mitigating macrophage polarization via modulation of the phosphoinositide 3-kinase/protein kinase B signaling pathway. World J Diabetes 2025; 16(2): 97287
- URL: https://www.wjgnet.com/1948-9358/full/v16/i2/97287.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i2.97287